日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Low-dose CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: a single-arm, open-label, phase Ia/Ib study

低剂量 CD7 嵌合抗原受体 T 细胞治疗复发/难治性 T 细胞淋巴瘤:一项单臂、开放标签的 Ia/Ib 期研究

Yang, Fan; Liu, Rui; Fu, Zhonghua; Guo, Yuelu; Ma, Lixia; Cao, Miaomiao; Deng, Biping; Chang, Alex H; Wu, Haifeng; Gan, Shilin; Chen, Chen; Ke, Xiaoyan; Hu, Kai

Efficacy of BCMA CAR-T cell therapy and subsequent strategies in refractory and relapsed plasma cell leukemia: a retrospective cohort study

BCMA CAR-T细胞疗法及其后续策略在难治性和复发性浆细胞白血病中的疗效:一项回顾性队列研究

Guo, Yuelu; Ma, Lixia; Yang, Fan; Fu, Zhonghua; Li, Danyang; Liu, Rui; Cao, Miaomiao; Wei, Bian; Dou, Yimeng; Deng, Biping; Gan, Shilin; Chang, Alex H; Ke, Xiaoyan; Hu, Kai

Outcomes in patients with refractory/relapsed CNS lymphoma treated in complete remission: autologous transplantation vs. CAR-T therapy

难治性/复发性中枢神经系统淋巴瘤患者完全缓解后接受自体移植与CAR-T疗法的疗效比较

Yang, Fan; Liu, Rui; Fu, Zhonghua; Guo, Yuelu; Ma, Lixia; Cao, Miaomiao; Deng, Biping; Wu, Haifeng; Chen, Chen; Ke, Xiaoyan; Hu, Kai

Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study

自体干细胞移植联合嵌合抗原受体T细胞疗法治疗难治性/复发性B细胞淋巴瘤:一项单臂临床研究

Li, Danyang; Liu, Rui; Fu, Zhonghua; Yang, Fan; Ma, Lixia; Guo, Yuelu; Cao, Miaomiao; Lei, Yang; Dou, Yimeng; Zhang, Xuenan; Gao, Yan; Wei, Bian; Deng, Biping; Ke, Xiaoyan; Hu, Kai

The safety and effectiveness of sintilimab versus camrelizumab, both plus targeted drugs, in advanced hepatocellular carcinoma

信迪利单抗与卡瑞利珠单抗联合靶向药物治疗晚期肝细胞癌的安全性和有效性比较

Zhao, Chenglong; Zhu, Qiongni; Qian, Xiaoyan; Fu, Zhonghua; Zhang, Wei; Wang, Yaqin

Antiepileptic drugs and foetal disorders: analysis of 20-year data from the pharmacovigilance center

抗癫痫药物与胎儿疾病:药物警戒中心20年数据分析

Ji, Zejun; Nie, Jianjun; Shen, Qingli; Fu, Zhonghua

Fu's subcutaneous needling facilitates muscle repair by regulating mitochondrial homeostasis in rat with chronic peripheral nervous pain.

傅氏皮下针刺疗法通过调节患有慢性周围神经疼痛的大鼠的线粒体稳态来促进肌肉修复

Chiu Po-En, Fu Zhonghua, Pan Hung-Chuan, Tsai Yi-Ching, Tsai Chia-Yun, Hsu Wei-Jen, Chou Li-Wei, Lai De-Wei

CAR T- cell therapy provides an opportunity for further consolidation treatment for relapsed or refractory adult Burkitt lymphoma patients

CAR-T细胞疗法为复发或难治性成人伯基特淋巴瘤患者提供了进一步巩固治疗的机会。

Liu, Rui; Yang, Fan; Ma, Lixia; Guo, Yuelu; Cao, Miaomiao; Fu, Zhonghua; Deng, Biping; Zheng, Qinlong; Chen, Chen; Li, Danyang; Ke, Xiaoyan; Hu, Kai

Chimeric antigen receptor (CAR) -T cell therapy treatment Richter's transformation

嵌合抗原受体(CAR)-T细胞疗法治疗里氏转化

Feng, Shaomei; Zheng, Peihao; Liu, Haidi; Sun, Meiling; Guo, Yuelu; Ma, Lixia; Liu, Rui; Fu, Zhonghua; Yang, Fan; Ke, Xiaoyan; Hu, Kai

CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier

CAR-T细胞疗法治疗TP53突变型中枢神经系统淋巴瘤:克服高风险遗传障碍

Li, Danyang; Liu, Rui; Fu, Zhonghua; Yang, Fan; Ma, Lixia; Cao, Miaomiao; Guo, Yuelu; Deng, Biping; Chang, Alex H; Zheng, Qinlong; Ke, Xiaoyan; Hu, Kai